In line with the PBMC data, IL1R5 and IL1R8 were also expressed in the NAWM of brain MS samples, and the level of IL1R5 tended to increase in active lesions (Figure 6E-F). This evidence concerns the gene IL1RAPL1 and myeloid sarcoma.